Mechanistically, we further demonstrated that celecoxib abrogated the activation of Akt/mTOR signalling in insulin‐stimulated hepatoma cells, followed by the reduction of downstream lipogenic proteins at the post‐transcriptional level in chronically insulin‐treated cohorts. This evidence concerns the gene AKT1 and hepatocellular carcinoma.